RecruitingNCT06336057

Mentalizating in Adults Suffering from Narcolepsy Type 1.

Mentalizating in Adults Suffering from Narcolepsy Type 1, a Comparative Prospective Study.


Sponsor

University Hospital, Toulouse

Enrollment

60 participants

Start Date

May 17, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The main objective is to examine the potential mentalization impairments affecting a population suffering from narcolepsy type 1. Indeed, the hypothesis of this research is that mentalization could be impaired in narcoleptic patients.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • For the NT1 patient group:
  • Adult patient having been diagnosed with type 1 narcolepsy according to ICSD 3 criteria and the completion of a 48-hour polysomnography at the Sleep Laboratory
  • Patient affiliated to or beneficiary of a social security system
  • For the control group:
  • Patient over 18 years old
  • Patient followed at Toulouse University Hospital and treated for Obstructive sleep apnea (OSA) with a residual AHI <5/h, demonstrating the absence of residual OSA under treatment
  • Patient affiliated to or beneficiary of a social security system

Exclusion Criteria5

  • Patient with a history of autism spectrum disorder, chronic psychotic disorder, or bipolar disorder.
  • Patient with a history of cognitive disorders of neurological origin
  • Patient with a linguistic level in French that does not allow sufficient understanding to complete the questionnaires
  • Patient under legal protection measure, under guardianship or curatorship
  • Pregnant or breastfeeding woman

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMentalization

complete several questionnaires including the RFQ (reflective functioning questionnaire) and the MST (Mental states task) which are validated questionnaires about mentalization


Locations(1)

University Hospital Toulouse, Centre de compétence Narcolepsies et Hypersomnies rares, Hôpital Pierre-Paul Riquet

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06336057


Related Trials